KEY PRODUCTS
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1Seqens
01 1OXYBUTYNIN BASE
01 1France
01 1Active
01 1Complete
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-04
Pay. Date : 2013-08-21
DMF Number : 13084
Submission : 1998-07-22
Status : Active
Type : II
20
Pcas, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
One of their notable products is OXYBUTYNIN BASE, with a corresponding US DMF Number 13084.
Remarkably, this DMF maintains an Active status since its submission on July 22, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 04, 2013, and payment made on August 21, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
